Safety and Efficacy of the Modified Vaccinia Ankara–Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis
Y Pang, D Cao, X Zhu, Q Long, F Tian, X Long… - Viral Immunology, 2024 - liebertpub.com
In May 2022, mpox began to spread worldwide, posing a serious threat to human public
health. Modified Vaccinia Ankara–Bavaria Nordic (MVA–BN) is a live attenuated …
health. Modified Vaccinia Ankara–Bavaria Nordic (MVA–BN) is a live attenuated …
Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross …
H Liu, W Wang, Y Zhang, F Wang, J Duan… - Emerging Microbes & …, 2024 - Taylor & Francis
A large outbreak of monkeypox occurred in 2022, and most people lack immunity to
orthopoxvirus. Smallpox vaccination is essential for preventing further smallpox outbreaks …
orthopoxvirus. Smallpox vaccination is essential for preventing further smallpox outbreaks …
Safety of monkeypox vaccine using active surveillance, two-center observational study in Italy
In August 2022, Italy launched a vaccination campaign to combat the spread of the
monkeypox virus, which the WHO has designated as a public health emergency. Priority …
monkeypox virus, which the WHO has designated as a public health emergency. Priority …
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV …
Background Pre-exposure vaccination with MVA-BN has been widely used against mpox to
contain the 2022 outbreak. Many countries have defined prioritized strategies, administering …
contain the 2022 outbreak. Many countries have defined prioritized strategies, administering …
An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge
E Li, Q Gong, J Zhang, X Guo, W Xie, D Chen, Y Shen… - Antiviral Research, 2024 - Elsevier
The outbreak of 2022 monkeypox virus (MPXV) infection in nonendemic regions is a global
public health concern. A highly effective and safe MPXV vaccine that is available to the …
public health concern. A highly effective and safe MPXV vaccine that is available to the …
Vaccines against Mpox: MVA-BN and LC16m8
JD Grabenstein, A Hacker - Expert Review of Vaccines, 2024 - Taylor & Francis
Introduction Global outbreaks involving mpox clade IIb began in mid-2022. Today, clade IIb
and clade I outbreaks continue. Reliable mpox vaccines can prevent serious mpox disease …
and clade I outbreaks continue. Reliable mpox vaccines can prevent serious mpox disease …
Stigmatization and Preferences in Monkeypox Vaccine Regimens
YH Shen, HH Chang, CY Tou, YC Lee, YH Lee… - Archives of Sexual …, 2024 - Springer
A significant monkeypox (mpox) outbreak occurred in 2022, particularly involving sexual and
gender minority (SGM) groups. Stigma and misperceptions have led to fear of being labeled …
gender minority (SGM) groups. Stigma and misperceptions have led to fear of being labeled …
Safety and Effectiveness of LC16m8 for Pre-Exposure Prophylaxis against mpox in a High-Risk Population: An Open-Label Randomized Trial
N Okumura, E Morino, H Nomoto, M Yanagi… - medRxiv, 2024 - medrxiv.org
Background The incidence of mpox cases has surged outside endemic regions since May
2022. However, data regarding the safety and efficacy of the LC16m8 vaccine are limited …
2022. However, data regarding the safety and efficacy of the LC16m8 vaccine are limited …
Mpox vaccination routes: prevalence, correlates and adverse effects of subcutaneous versus intradermal vaccination at a mass vaccination clinic in Sydney, Australia
A Pollack, W Lo, H Imamura… - Internal Medicine …, 2024 - Wiley Online Library
Abstract The Royal Prince Alfred Hospital Mpox Vaccination Clinic opened in response to
the 2022 multicountry mpox outbreak. A total of 9500 vaccinations were administered …
the 2022 multicountry mpox outbreak. A total of 9500 vaccinations were administered …
[HTML][HTML] Adverse Reactions After Intradermal Vaccination With JYNNEOS for Mpox in Korea
SY Lim, YM Jung, Y Kim, G Kim, J Jeon… - Journal of Korean …, 2024 - ncbi.nlm.nih.gov
In response to the Mpox domestic epidemic, South Korea initiated a nationwide vaccination
program in May 2023, administering a 0.1 mL intradermal dose of JYNNEOS (Modified …
program in May 2023, administering a 0.1 mL intradermal dose of JYNNEOS (Modified …